Background. Rheumatoid arthritis (RA) is a common autoimmune disease. Current therapies, including anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs and biologic agents, have limitations such as adverse effects and loss of efficacy. The conditioned medium of mesenchymal stem cells (CM-MSC) may offer an alternative due to its regenerative and immunomodulatory properties.
The objective of the study was to characterize the anti-inflammatory and analgesic activity of the CM-MSC in an adjuvant arthritis (АА) model in rats.
Materials and methods. CM-MSC was obtained by culturing umbilical mesenchymal stem cells (MSCs) in serum-free medium, filtering, and standardizing for galectin-1 content (6.0 pg/mL). It was administered intramuscularly to rats at a dose of 0.6 ml/kg body weight. AA was induced by injecting complete Freund’s adjuvant into the right hind limb. Treatments were given from day 14 to 28 post-induction. The anti-inflammatory activity was measured by changes in limb volume, while analgesic activity was assessed via mechanical compression. Rats were divided into four groups: control, diclofenac sodium, CM-MSC, and saline.
Results. CM-MSC reduced paw edema by 22.0% (p = 0.01) and increased the pain threshold by 42.7% (p < 0.01) in a rat model of AA. Diclofenac sodium produced more pronounced effects; however, CM-MSC still demonstrated statistically significant anti-inflammatory and analgesic activity.
Conclusions. These findings suggest that CM-MSC holds promise as a cell-free therapeutic approach for managing chronic inflammation and pain in rheumatoid arthritis. Further studies are needed to elucidate the underlying mechanisms and optimize treatment protocols.
Keywords: mesenchymal stem cells, rheumatoid arthritis, adjuvant arthritis, autoimmune diseases, stem cell therapy.
Address for correspondence:
Fedir HLADKYKH
Department of Infectious Diseases and Clinical Immunology, School of Medicine, V. N. Karazin Kharkiv National University
Address: 4, Svobody Sq, Kharkiv 61022, Ukraine
Е-mail: fedir.hladkykh@gmail.com; Phone: +38099782787